Myostatin/activin blocking combined with exercise reconditions skeletal muscle expression profile of mdx mice

Molecular and Cellular Endocrinology

Volumn 399, Issue , 2015, Pages 131-142

  Kainulainen, Heikki ^a   Papaioannou, Konstantinos G ^a   Silvennoinen, Mika ^a   Autio, Reija ^b   Saarela, Janne ^a   Oliveira, Bernardo M ^a   Nyqvist, Miro ^c   Pasternack, Arja ^d   't Hoen, Peter A C ^e   Kujala, Urho M ^a   Ritvos, Olli ^d   Hulmi, Juha J ^a  

^a UNIVERSITY OF JYVÄSKYLÄ   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Mrna profiling; Muscle hypertrophy; Muscular dystrophy; Oxidative metabolism; Physical activity

Indexed keywords

ACTIVIN; MYOSTATIN; RIBOSOME RNA; STAT5 PROTEIN; ACTIVIN RECEPTOR 2; ACTIVIN RECEPTOR TYPE II-B; HYBRID PROTEIN; INHIBIN; INHIBIN BETA A SUBUNIT; MSTN PROTEIN, MOUSE;

AEROBIC METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA CONTENT; DUCHENNE MUSCULAR DYSTROPHY; GASTROCNEMIUS MUSCLE; GENE EXPRESSION REGULATION; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PHARMACOLOGICAL BLOCKING; PHYSICAL ACTIVITY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RESPIRATORY CHAIN; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; GENETICS; METABOLISM; PHOSPHORYLATION; SKELETAL MUSCLE; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

ACTIVIN RECEPTORS, TYPE II; ANIMALS; INHIBIN-BETA SUBUNITS; MICE; MICE, INBRED MDX; MUSCLE, SKELETAL; MYOSTATIN; PHOSPHORYLATION; PHYSICAL CONDITIONING, ANIMAL; RECOMBINANT FUSION PROTEINS; STAT5 TRANSCRIPTION FACTOR;

EID: 84908583853     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2014.10.001     Document Type: Article

References (67)

1. Amthor H., Hoogaars W.M. Interference with myostatin/ActRIIB signaling as a therapeutic strategy for Duchenne muscular dystrophy. Curr. Gene Ther 2012, 12:245-259.
2. Amthor H., Macharia R., Navarrete R., Schuelke M., Brown S.C., Otto A., et al. Lack of myostatin results in excessive muscle growth but impaired force generation. Proc. Natl Acad. Sci. U.S.A. 2007, 104:1835-1840.
3. Ashburner M., Ball C.A., Blake J.A., Botstein D., Butler H., Cherry J.M., et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet 2000, 25:25-29.
4. Attie K.M., Borgstein N.G., Yang Y., Condon C.H., Wilson D.M., Pearsall A.E., et al. A single ascending-dose study of muscle regulator ace-031 in healthy volunteers. Muscle Nerve 2013, 47:416-423.
5. Basco D., Blaauw B., Pisani F., Sparaneo A., Nicchia G.P., Mola M.G., et al. AQP4-dependent water transport plays a functional role in exercise-induced skeletal muscle adaptations. PLoS ONE 2013, 8:e58712.
6. Biesiadecki B.J., Brand P.H., Koch L.G., Britton S.L. A gravimetric method for the measurement of total spontaneous activity in rats. Proc. Soc. Exp. Biol. Med 1999, 222:65-69.
7. Blair S.N., Kohl H.W., Paffenbarger R.S., Clark D.G., Cooper K.H., Gibbons L.W. Physical fitness and all-cause mortality. A prospective study of healthy men and women. JAMA 1989, 262:2395-2401.
8. Booth F.W., Laye M.J. Lack of adequate appreciation of physical exercise's complexities can pre-empt appropriate design and interpretation in scientific discovery. J. Physiol 2009, 587:5527-5539.
9. Call J.A., Voelker K.A., WolffA.V., McMillan R.P., Evans N.P., Hulver M.W., et al. Endurance capacity in maturing mdx mice is markedly enhanced by combined voluntary wheel running and green tea extract. J. Appl. Physiol 2008, 105:923-932.
10. Chelh I., Meunier B., Picard B., Reecy J.M., Chevalier C., Hocquette J.F., et al. Molecular profiles of quadriceps muscle in myostatin-null mice reveal PI3K and apoptotic pathways as myostatin targets. BMC Genomics 2009, 10:196.
11. Chen J., Sadowski H.B., Kohanski R.A., Wang L.H. Stat5 is a physiological substrate of the insulin receptor. Proc. Natl Acad. Sci. U.S.A. 1997, 94:2295-2300.
12. Chinsomboon J., Ruas J., Gupta R.K., Thom R., Shoag J., Rowe G.C., et al. The transcriptional coactivator PGC-1alpha mediates exercise-induced angiogenesis in skeletal muscle. Proc. Natl Acad. Sci. U.S.A. 2009, 106:21401-21406.
13. Coffey V.G., Shield A., Canny B.J., Carey K.A., Cameron-Smith D., Hawley J.A. Interaction of contractile activity and training history on mRNA abundance in skeletal muscle from trained athletes. Am. J. Physiol. Endocrinol. Metab 2006, 290:E849-E855.
14. Colussi C., BanfiC., Brioschi M., Tremoli E., Straino S., Spallotta F., et al. Proteomic profile of differentially expressed plasma proteins from dystrophic mice and following suberoylanilide hydroxamic acid treatment. Proteomics Clin. Appl 2010, 4:71-83.
15. Dennis G., Sherman B.T., Hosack D.A., Yang J., Gao W., Lane H.C., et al. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 2003, 4:P3.
16. Egan B., Zierath J.R. Exercise metabolism and the molecular regulation of skeletal muscle adaptation. Cell Metab 2013, 17:162-184.
17. Evans N.P., Misyak S.A., Robertson J.L., Bassaganya-Riera J., Grange R.W. Dysregulated intracellular signaling and inflammatory gene expression during initial disease onset in Duchenne muscular dystrophy. Am. J. Phys. Med. Rehabil 2009, 88:502-522.
18. Even P.C., Decrouy A., Chinet A. Defective regulation of energy metabolism in mdx-mouse skeletal muscles. Biochem. J. 1994, 304(Pt 2):649-654.
19. Frigeri A., Nicchia G.P., Repetto S., Bado M., Minetti C., Svelto M. Altered aquaporin-4 expression in human muscular dystrophies: a common feature?. FASEB J. 2002, 16:1120-1122.
20. Grange R.W., Call J.A. Recommendations to define exercise prescription for Duchenne muscular dystrophy. Exerc. Sport Sci. Rev 2007, 35:12-17.
21. Hara H., Nolan P.M., Scott M.O., Bucan M., Wakayama Y., Fischbeck K.H. Running endurance abnormality in mdx mice. Muscle Nerve 2002, 25:207-211.
22. Hoogaars W.M., Mouisel E., Pasternack A., Hulmi J.J., Relizani K., Schuelke M., et al. Combined effect of AAV-U7-induced dystrophin exon skipping and soluble activin Type IIB receptor in mdx mice. Hum. Gene Ther 2012, 23:1269-1279.
23. Hui X., Zhu W., Wang Y., Lam K.S., Zhang J., Wu D., et al. Major urinary protein-1 increases energy expenditure and improves glucose intolerance through enhancing mitochondrial function in skeletal muscle of diabetic mice. J. Biol. Chem 2009, 284:14050-14057.
24. Hulmi J.J., Oliveira B.M., Silvennoinen M., Hoogaars W.M., Ma H., Pierre P., et al. Muscle protein synthesis, mTORC1/MAPK/Hippo signaling, and capillary density are altered by blocking of myostatin and activins. Am. J. Physiol. Endocrinol. Metab 2013, 304:E41-E50.
25. Hulmi J.J., Oliveira B.M., Silvennoinen M., Hoogaars W.M., Pasternack A., Kainulainen H., et al. Exercise restores decreased physical activity levels and increases markers of autophagy and oxidative capacity in myostatin/activin-blocked mdx mice. Am. J. Physiol. Endocrinol. Metab 2013, 305:E171-E182.
26. Jansen M., van Alfen N., Geurts A.C., de Groot I.J. Assisted bicycle training delays functional deterioration in boys with duchenne muscular dystrophy: the randomized controlled trial "no use is disuse". Neurorehabil. Neural Repair 2013, 27:816-827.
27. Kainulainen H., Hulmi J.J., Kujala U.M. Potential role of branched-chain amino acid catabolism in regulating fat oxidation. Exerc. Sport Sci. Rev 2013, 41:194-200.
28. Kalista S., Schakman O., Gilson H., Lause P., Demeulder B., Bertrand L., et al. The type 1 insulin-like growth factor receptor (IGF-IR) pathway is mandatory for the follistatin-induced skeletal muscle hypertrophy. Endocrinology 2012, 153:241-253.
29. Kallio M.A., Tuimala J.T., Hupponen T., Klemela P., Gentile M., Scheinin I., et al. Chipster: user-friendly analysis software for microarray and other high-throughput data. BMC Genomics 2011, 12. 507-2164-12-507.
30. Kanehisa M., Araki M., Goto S., Hattori M., Hirakawa M., Itoh M., et al. KEGG for linking genomes to life and the environment. Nucleic Acids Res 2008, 36:D480-D484.
31. Kivelä R., Silvennoinen M., Lehti M., Rinnankoski-Tuikka R., Purhonen T., Ketola T., et al. Gene expression centroids that link with low intrinsic aerobic exercise capacity and complex disease risk. FASEB J. 2010, 24:4565-4574.
32. Klover P., Hennighausen L. Postnatal body growth is dependent on the transcription factors signal transducers and activators of transcription 5a/b in muscle: a role for autocrine/paracrine insulin-like growth factor I. Endocrinology 2007, 148:1489-1497.
33. Koenig M., Hoffman E.P., Bertelson C.J., Monaco A.P., Feener C., Kunkel L.M. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 1987, 50:509-517.
34. Kujala U.M., Kaprio J., Sarna S., Koskenvuo M. Relationship of leisure-time physical activity and mortality: the Finnish twin cohort. JAMA 1998, 279:440-444.
35. Kujala U.M., Makinen V.P., Heinonen I., Soininen P., Kangas A.J., Leskinen T.H., et al. Long-term leisure-time physical activity and serum metabolome. Circulation 2013, 127:340-348.
36. Kuznetsov A.V., Winkler K., Wiedemann F.R., von Bossanyi P., Dietzmann K., Kunz W.S. Impaired mitochondrial oxidative phosphorylation in skeletal muscle of the dystrophin-deficient mdx mouse. Mol. Cell. Biochem 1998, 183:87-96.
37. Landisch R.M., Kosir A.M., Nelson S.A., Baltgalvis K.A., Lowe D.A. Adaptive and nonadaptive responses to voluntary wheel running by mdx mice. Muscle Nerve 2008, 38:1290-1303.
38. LeBrasseur N.K., Schelhorn T.M., Bernardo B.L., Cosgrove P.G., Loria P.M., Brown T.A. Myostatin inhibition enhances the effects of exercise on performance and metabolic outcomes in aged mice. J. Gerontol. A. Biol Sci. Med Sci 2009, 64:940-948.
39. Lee S.J., Reed L.A., Davies M.V., Girgenrath S., Goad M.E., Tomkinson K.N., et al. Regulation of muscle growth by multiple ligands signaling through activin type II receptors. Proc. Natl Acad. Sci. U.S.A. 2005, 102:18117-18122.
40. Leskinen T., Rinnankoski-Tuikka R., Rintala M., Seppanen-Laakso T., Pollanen E., Alen M., et al. Differences in muscle and adipose tissue gene expression and cardio-metabolic risk factors in the members of physical activity discordant twin pairs. PLoS ONE 2010, 5. 10.1371/journal.pone.0012609.
41. Ljubicic V., Miura P., Burt M., Boudreault L., Khogali S., Lunde J.A., et al. Chronic AMPK activation evokes the slow, oxidative myogenic program and triggers beneficial adaptations in mdx mouse skeletal muscle. Hum. Mol. Genet 2011, 20:3478-3493.
42. Ljubicic V., Burt M., Jasmin B.J. The therapeutic potential of skeletal muscle plasticity in Duchenne muscular dystrophy: phenotypic modifiers as pharmacologic targets. FASEB J. 2014, 28:548-568.
43. Matsakas A., Mouisel E., Amthor H., Patel K. Myostatin knockout mice increase oxidative muscle phenotype as an adaptive response to exercise. J. Muscle Res. Cell Motil 2010, 31:111-125.
44. Matsakas A., Macharia R., Otto A., Elashry M.I., Mouisel E., Romanello V., et al. Exercise training attenuates the hypermuscular phenotype and restores skeletal muscle function in the myostatin null mouse. Exp. Physiol 2012, 97:125-140.
45. McPherron A.C., Lee S.J. Double muscling in cattle due to mutations in the myostatin gene. Proc. Natl Acad. Sci. U.S.A. 1997, 94:12457-12461.
46. Mero A.A., Hulmi J.J., Salmijarvi H., Katajavuori M., Haverinen M., Holviala J., et al. Resistance training induced increase in muscle fiber size in young and older men. Eur. J. Appl. Physiol 2013, 113:641-650.
47. Mikus C.R., Boyle L.J., Borengasser S.J., Oberlin D.J., Naples S.P., Fletcher J., et al. Simvastatin impairs exercise training adaptations. J. Am. Coll. Cardiol 2013.
48. Moens P., Baatsen P.H., Marechal G. Increased susceptibility of EDL muscles from mdx mice to damage induced by contractions with stretch. J. Muscle Res. Cell Motil 1993, 14:446-451.
49. Mootha V.K., Lindgren C.M., Eriksson K.F., Subramanian A., Sihag S., Lehar J., et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet 2003, 34:267-273.
50. Nicchia G.P., Cogotzi L., Rossi A., Basco D., Brancaccio A., Svelto M., et al. Expression of multiple AQP4 pools in the plasma membrane and their association with the dystrophin complex. J. Neurochem 2008, 105:2156-2165.
51. Personius K.E., Jayaram A., Krull D., Brown R., Xu T., Han B., et al. Grip force, EDL contractile properties, and voluntary wheel running after postdevelopmental myostatin depletion in mice. J. Appl. Physiol 2010, 109:886-894.
52. Pistilli E.E., Bogdanovich S., Goncalves M.D., Ahima R.S., Lachey J., Seehra J., et al. Targeting the activin type IIB receptor to improve muscle mass and function in the mdx mouse model of Duchenne muscular dystrophy. Am. J. Pathol 2011, 178:1287-1297.
53. Ploquin C., Chabi B., Fouret G., Vernus B., Feillet-Coudray C., Coudray C., et al. Lack of myostatin alters intermyofibrillar mitochondria activity, unbalances redox status, and impairs tolerance to chronic repetitive contractions in muscle. Am. J. Physiol. Endocrinol. Metab 2012, 302:E1000-E1008.
54. Rahimov F., King O.D., Warsing L.C., Powell R.E., Emerson C.P., Kunkel L.M., et al. Gene expression profiling of skeletal muscles treated with a soluble activin type IIB receptor. Physiol. Genomics 2011, 43:398-407.
55. Rantalainen T., Silvennoinen M., Kainulainen H., Sievanen H. Vertical ground reaction force measurements and video measurements provide comparable estimates of distance moved by mice during artificial light and dark periods. J. Neurosci. Methods 2011, 197:104-108.
56. Relizani K., Mouisel E., Giannesini B., Hourde C., Patel K., Morales Gonzalez S., et al. Blockade of ActRIIB signaling triggers muscle fatigability and metabolic myopathy. Mol. Ther 2014, 22:1423-1433.
57. Silvennoinen M., Rantalainen T., Kainulainen H. Validation of a method to measure total spontaneous physical activity of sedentary and voluntary running mice. J. Neurosci. Methods 2014, 235C:51-58.
58. Smyth G.K. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol 2004, 3:Article3.
59. Smyth G.K., Speed T. Normalization of cDNA microarray data. Methods 2003, 31:265-273.
60. Subramanian A., Tamayo P., Mootha V.K., Mukherjee S., Ebert B.L., Gillette M.A., et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. U.S.A. 2005, 102:15545-15550.
61. Sugden M.C., Holness M.J. Recent advances in mechanisms regulating glucose oxidation at the level of the pyruvate dehydrogenase complex by PDKs. Am. J. Physiol. Endocrinol. Metab 2003, 284:E855-E862.
62. Timmons J.A., Larsson O., Jansson E., Fischer H., Gustafsson T., GreenhaffP.L., et al. Human muscle gene expression responses to endurance training provide a novel perspective on Duchenne muscular dystrophy. FASEB J. 2005, 19:750-760.
63. Wagenmakers A.J. Muscle amino acid metabolism at rest and during exercise: role in human physiology and metabolism. Exerc. Sport Sci. Rev 1998, 26:287-314.
64. Webster C., Silberstein L., Hays A.P., Blau H.M. Fast muscle fibers are preferentially affected in Duchenne muscular dystrophy. Cell 1988, 52:503-513.
65. Welle S., Bhatt K., Pinkert C.A. Myofibrillar protein synthesis in myostatin-deficient mice. Am. J. Physiol. Endocrinol. Metab 2006, 290:E409-E415.
66. Zhao B., Li E.J., Wall R.J., Yang J. Coordinated patterns of gene expressions for adult muscle build-up in transgenic mice expressing myostatin propeptide. BMC Genomics 2009, 10. 305-2164-10-305.
67. Zhou X., Wang J.L., Lu J., Song Y., Kwak K.S., Jiao Q., et al. Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival. Cell 2010, 142:531-543.